Data / Form D filings / GEMA DIAGNOSTICS, INC.
GEMA DIAGNOSTICS, INC.: Form D filing
GEMA DIAGNOSTICS, INC., a biotechnology company in Ann Arbor, MI, filed a Form D with the SEC in 2013. The latest, on March 27, 2013, reports $2.7 million sold of a $3.8 million offering to 7 investors.
Find out what GEMA DIAGNOSTICS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 206 S. FIFTH AVENUE, SUITE 550, Ann Arbor, MI, 48104
- Phone
- (734) 662-6261
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Michigan
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506, Securities Act section 4(6)
- SEC identifier (CIK)
- 1355650
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 27, 2013 | New notice | $3,750,000 | $2,665,127 | $1,084,873 | 7 | Mar 15, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jose Bernardo Cibelli | Director | |
| Lindsay Douglas Aspegren | Director | |
| David Lyman Repp | Executive Officer, Director | |
| Charles Robert Burke | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Mar 25, 2013 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GEMA DIAGNOSTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.